BCDA vs CVS · $14.4M cap vs P/E 16, rev $402.07B
Biocardia Inc (BCDA) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Biocardia Inc (BCDA) is a biotechnology company listed on NASDAQ.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
BCDA does not have a complete income-statement cache yet.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
BCDA currently screens at market cap $14.4M. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the BCDA and CVS stock pages for the full models.
Not investment advice.